SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-16-664791
Filing Date
2016-07-29
Accepted
2016-07-29 17:11:02
Documents
2
Group Members
BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND IV, L.P.BAY CITY CAPITAL MANAGEMENT IV LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d233253dsc13d.htm SC 13D 97544
2 EX-99.1 d233253dex991.htm EX-99.1 2264
  Complete submission text file 0001193125-16-664791.txt   101489
Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 415.676.3830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034 949-725-4277
Madrigal Pharmaceuticals, Inc. (Subject) CIK: 0001673226 (see all company filings)

IRS No.: 453050834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89582 | Film No.: 161794886